Tove Jensen-Munroe

Tove Jensen-Munroe is a cancer survivor living in Rotorua, New Zealand, who has bravely battled AL amyloidosis and multiple myeloma since her diagnosis in 2016. After experiencing severe heart failure and undergoing aggressive treatments, including chemotherapy and a stem cell transplant, she has become an advocate for the funding of critical cancer medications, particularly daratumumab, which is not currently funded in New Zealand but is essential for many patients like her.